PRECISIONheor Featured Oncology Publications
PRECISIONheor experts have led research in a number of innovative oncology studies, making it possible for important new treatments to get into the hands of patients who need them the most.
Conference: Virtual ISPOR 2021
Did you miss PRECISIONheor at Virtual ISPOR 2021? Find out more about what was presented at the conference and download our available posters here.
The Importance of Qualitative Research in Enhancing Understanding of Treatment Decisions, Outcomes, and Value Assessment
Despite the strengths and historical dominance of quantitative research in the health care domain, the importance of rigorous qualitative research as both a complement to, and a mechanism for, augmenting quantitative methods is increasingly being recognized and used across health-related disciplines.
Understanding the Impact of COVID-19 on Schizophrenia Population Health Management: A Mixed-Methods Study of Population Health Decision Makers
In “Understanding the Impact of COVID-19 on Schizophrenia Population Health Management: A Mixed-Methods Study of Population Health Decision Makers”, PRECISIONheor authors Marlon Graf, Meaghan Roach, Priti Pednekar, and Jacki Chou sought to understand PHDMs’ perceptions of challenges, policies, and programs related to schizophrenia population health management, both generally and in the context of the COVID-19 pandemic.
NCCN 2021 Virtual Annual Conference
Congratulations to PRECISIONheor’s Meaghan Roach MPH, Caroline Huber MPH, Suepattra May-Slater MPH, PhD, and Isha Desai MPH on the successful presentation of their poster "A Qualitative Study Describing Oncology Practitioners’ Approaches to First-Line (1L) Treatment of Metastatic Urothelial Cancer (mUC) in the United States" at NCCN 2021.
CGRPs for Migraine Play Role in Value-Based Contracting
Despite a slew of new branded therapies for acute migraine treatment and migraine prevention, many of which target calcitonin gene-related peptide (CGRP) receptors, drug benefits experts say that health plans and PBMs continue to rely mainly on generic triptans for acute migraine treatment and generic beta-blockers, antiepileptics and tricyclic antidepressants for migraine prevention. Precision's Jacki Chou joins an expert discussion about developing patient-specific migraine treatment plans and the potential growth of value-based therapies.
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
Precision's Marlon Graf and Rifat Tuly identify two components that are required for continued success with COVID-19 vaccine policies, and discuss ways to address them to ensure that the discovery and development of new vaccines for COVID-19 and future pandemics can be sustained in the future.
COVID-19: Models, Mathematics, and Myths
Researchers have introduced mathematical models of varying complexity over the past several months to capture different aspects of COVID-19’s dynamics, with limited to no implications for healthcare decision-makers. Why? Precision's Anuj Mubayi and Ross Maclean identify the five myths surrounding COVID-19 mathematical models, and share potential answers regarding the extent to which each myth is addressed in the existing models.
Precision Medicine Group Significantly Expands Cell and Gene Therapy Expertise with Acquisition of Project Farma
LEADING BIO-ENGINEERING AND MANUFACTURING SERVICES FIRM CATALYZES THE LAUNCH OF PRECISION’S CELL AND GENE THERAPY OFFERING—'PRECISION ADVANCE’—ADDRESSING THE UNIQUE CHALLENGES OF CELL & GENE THERAPY INNOVATORS, FROM DEVELOPMENT THROUGH COMMERCIALIZATION
Does COVID-19 Threaten the Progress Pharmaceuticals Have Made in Reducing Cancer Mortality Over the Last 20 Years?
While the development and introduction of new pharmaceuticals have played a pivotal role in reducing US cancer deaths, winning the war on cancer is a multifaceted battle. Meanwhile, COVID-19 has affected virtually every aspect of cancer care, from the research and development of new therapies, to diagnosis and treatment.
